$16.6 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 136 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 60.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IQV | Buy | IQVIA HLDGS INC | $724,475,000 | +30.3% | 4,043,506 | +14.7% | 4.36% | +13.3% |
| GOOG | Sell | ALPHABET INCcap stk cl c | $632,593,000 | +18.7% | 361,094 | -0.4% | 3.80% | +3.2% |
| TMUS | Buy | T-MOBILE US INC | $532,547,000 | +28.0% | 3,949,181 | +8.6% | 3.20% | +11.3% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $518,994,000 | +7.3% | 1,114,248 | +1.7% | 3.12% | -6.7% |
| SPY | New | SPDR S&P 500 ETF TRput | $510,346,000 | – | 1,365,000 | +100.0% | 3.07% | – |
| V | Buy | VISA INC | $487,353,000 | +42.0% | 2,228,104 | +29.8% | 2.93% | +23.4% |
| AON | Buy | AON PLC | $479,903,000 | +32.4% | 2,271,514 | +29.3% | 2.89% | +15.2% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $475,918,000 | +50.5% | 13,238,319 | +60.0% | 2.86% | +30.9% |
| FIS | Sell | FIDELITY NATL INFORMATION SV | $445,474,000 | -4.3% | 3,149,118 | -0.4% | 2.68% | -16.8% |
| ARMK | New | ARAMARK | $424,202,000 | – | 11,023,949 | +100.0% | 2.55% | – |
| CNC | Sell | CENTENE CORP DEL | $411,206,000 | -0.0% | 6,850,000 | -2.8% | 2.47% | -13.0% |
| ANTM | ANTHEM INC | $409,390,000 | +19.5% | 1,275,000 | 0.0% | 2.46% | +3.9% | |
| MSFT | Buy | MICROSOFT CORP | $391,052,000 | +20.7% | 1,758,168 | +14.1% | 2.35% | +4.9% |
| WAB | Sell | WABTEC | $365,808,000 | +8.7% | 4,997,371 | -8.1% | 2.20% | -5.5% |
| XLNX | New | XILINX INC | $362,364,000 | – | 2,556,000 | +100.0% | 2.18% | – |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $361,822,000 | -21.0% | 546,931 | -25.4% | 2.18% | -31.3% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $351,056,000 | – | 2,246,900 | +100.0% | 2.11% | – |
| NYT | Sell | NEW YORK TIMES COcl a | $338,852,000 | +11.4% | 6,545,329 | -7.9% | 2.04% | -3.1% |
| XLRN | ACCELERON PHARMA INC | $332,644,000 | +13.7% | 2,600,000 | 0.0% | 2.00% | -1.1% | |
| RTX | New | RAYTHEON TECHNOLOGIES CORP | $324,820,000 | – | 4,542,306 | +100.0% | 1.95% | – |
| FB | Sell | FACEBOOK INCcl a | $315,228,000 | -21.9% | 1,154,005 | -25.2% | 1.90% | -32.1% |
| CRM | Buy | SALESFORCE COM INC | $313,555,000 | +78.7% | 1,409,045 | +101.8% | 1.89% | +55.4% |
| TIF | TIFFANY & CO NEW | $300,626,000 | +13.5% | 2,287,000 | 0.0% | 1.81% | -1.4% | |
| SHW | Sell | SHERWIN WILLIAMS CO | $286,149,000 | +1.2% | 389,366 | -4.0% | 1.72% | -12.0% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $278,400,000 | +42.0% | 6,000,000 | +0.8% | 1.67% | +23.5% |
| FATE | Sell | FATE THERAPEUTICS INC | $272,790,000 | +118.4% | 3,000,000 | -4.0% | 1.64% | +89.9% |
| AVGO | New | BROADCOM INC | $272,778,000 | – | 622,995 | +100.0% | 1.64% | – |
| BX | Buy | BLACKSTONE GROUP INC | $252,233,000 | +26.2% | 3,891,886 | +1.6% | 1.52% | +9.7% |
| EXEL | Buy | EXELIXIS INC | $220,770,000 | -16.0% | 11,000,000 | +2.3% | 1.33% | -27.0% |
| EDU | Sell | NEW ORIENTAL ED & TECHNOLOGYspon adr | $214,480,000 | +4.8% | 1,154,300 | -15.7% | 1.29% | -8.8% |
| WORK | New | SLACK TECHNOLOGIES INC | $207,496,000 | – | 4,912,300 | +100.0% | 1.25% | – |
| WLTW | Buy | WILLIS TOWERS WATSON PLC LTD | $202,780,000 | +1842.2% | 962,500 | +1825.0% | 1.22% | +1594.4% |
| IPHI | New | INPHI CORP | $198,951,000 | – | 1,239,800 | +100.0% | 1.20% | – |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $198,589,000 | +10.3% | 853,300 | +39.3% | 1.19% | -4.2% |
| MRTX | MIRATI THERAPEUTICS INC | $192,185,000 | +32.3% | 875,000 | 0.0% | 1.16% | +15.0% | |
| HLT | Buy | HILTON WORLDWIDE HLDGS INC | $182,515,000 | +38.4% | 1,640,437 | +6.1% | 1.10% | +20.4% |
| TRU | Sell | TRANSUNION | $172,056,000 | +12.7% | 1,734,082 | -4.4% | 1.04% | -2.0% |
| QGEN | New | QIAGEN NV | $172,120,000 | – | 3,256,771 | +100.0% | 1.04% | – |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $166,780,000 | -13.5% | 1,000,000 | -20.0% | 1.00% | -24.8% |
| HWM | Sell | HOWMET AEROSPACE INC | $139,603,000 | +15.8% | 4,891,479 | -32.2% | 0.84% | +0.7% |
| MXIM | Buy | MAXIM INTEGRATED PRODS INC | $136,734,000 | +64.4% | 1,542,400 | +25.4% | 0.82% | +43.0% |
| APLS | APELLIS PHARMACEUTICALS INC | $130,130,000 | +89.6% | 2,275,000 | 0.0% | 0.78% | +64.8% | |
| ABBV | Sell | ABBVIE INC | $123,223,000 | -66.9% | 1,150,000 | -72.9% | 0.74% | -71.2% |
| AMRS | Buy | AMYRIS INC | $108,063,000 | +164.3% | 17,500,000 | +25.0% | 0.65% | +129.7% |
| SRPT | SAREPTA THERAPEUTICS INC | $102,294,000 | +21.4% | 600,000 | 0.0% | 0.62% | +5.5% | |
| Buy | MOMO INCnote 1.250% 7/0 | $93,459,000 | +13.2% | 110,077,000 | +5.8% | 0.56% | -1.6% | |
| PCG | PG&E CORP | $90,859,000 | +32.7% | 7,292,042 | 0.0% | 0.55% | +15.2% | |
| SAGE | SAGE THERAPEUTICS INC | $90,836,000 | +41.5% | 1,050,000 | 0.0% | 0.55% | +23.0% | |
| PLYA | Sell | PLAYA HOTELS & RESORTS NV | $89,219,000 | -30.4% | 14,994,867 | -51.0% | 0.54% | -39.5% |
| LU | New | LUFAX HOLDING LTD | $76,080,000 | – | 5,357,750 | +100.0% | 0.46% | – |
| ENTA | ENANTA PHARMACEUTICALS INC | $74,728,000 | -8.0% | 1,775,000 | 0.0% | 0.45% | -20.1% | |
| BRMK | BROADMARK RLTY CAP INC | $73,136,000 | +3.4% | 7,170,213 | 0.0% | 0.44% | -10.0% | |
| KSU | Sell | KANSAS CITY SOUTHERN | $72,344,000 | +1.5% | 354,400 | -10.1% | 0.44% | -11.8% |
| Buy | IQIYI INCnote 2.000% 4/0 | $71,760,000 | +21.4% | 81,762,000 | +32.4% | 0.43% | +5.6% | |
| EFX | Sell | EQUIFAX INC | $71,483,000 | +14.9% | 370,684 | -6.5% | 0.43% | 0.0% |
| KRTX | KARUNA THERAPEUTICS INC | $71,113,000 | +31.4% | 700,000 | 0.0% | 0.43% | +14.4% | |
| FGEN | Buy | FIBROGEN INC | $70,471,000 | -7.4% | 1,900,000 | +2.7% | 0.42% | -19.4% |
| BCAB | New | BIOATLA INC | $66,900,000 | – | 1,967,060 | +100.0% | 0.40% | – |
| GBIO | Buy | GENERATION BIO CO | $64,321,000 | -1.9% | 2,268,819 | +7.0% | 0.39% | -14.6% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $57,623,000 | +22.3% | 750,000 | +19.1% | 0.35% | +6.4% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $54,474,000 | +35.8% | 2,100,000 | -48.3% | 0.33% | +18.4% |
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $53,806,000 | +8.0% | 56,695,000 | 0.0% | 0.32% | -6.1% | ||
| CYTK | Buy | CYTOKINETICS INC | $49,872,000 | +7.1% | 2,400,000 | +11.6% | 0.30% | -6.8% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $48,888,000 | -9.1% | 2,425,000 | -11.8% | 0.29% | -21.0% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $45,490,000 | -74.0% | 350,000 | -70.8% | 0.27% | -77.3% |
| ZGNX | ZOGENIX INC | $44,978,000 | +11.5% | 2,250,000 | 0.0% | 0.27% | -2.9% | |
| CLGX | Buy | CORELOGIC INC | $44,384,000 | +90.1% | 574,028 | +66.4% | 0.27% | +65.8% |
| Sell | KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $43,527,000 | -6.8% | 35,000,000 | -9.1% | 0.26% | -18.9% | |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $43,330,000 | +14.3% | 1,000,000 | -7.7% | 0.26% | -0.4% |
| IONS | New | IONIS PHARMACEUTICALS INC | $42,405,000 | – | 750,000 | +100.0% | 0.26% | – |
| ANNX | Sell | ANNEXON INC | $38,978,000 | -3.5% | 1,557,261 | -6.0% | 0.23% | -16.1% |
| RDUS | RADIUS HEALTH INC | $37,638,000 | +57.5% | 2,107,400 | 0.0% | 0.23% | +37.0% | |
| CARA | Buy | CARA THERAPEUTICS INC | $37,295,000 | +30.3% | 2,465,000 | +9.6% | 0.22% | +13.1% |
| New | INSMED INCnote 1.750% 1/1 | $36,552,000 | – | 32,500,000 | +100.0% | 0.22% | – | |
| CLOVIS ONCOLOGY INCnote 1.250% 5/0 | $36,077,000 | -0.5% | 51,910,000 | 0.0% | 0.22% | -13.5% | ||
| LNTH | LANTHEUS HLDGS INC | $35,749,000 | +6.5% | 2,650,000 | 0.0% | 0.22% | -7.3% | |
| ZYME | Sell | ZYMEWORKS INC | $35,445,000 | -10.7% | 750,000 | -12.0% | 0.21% | -22.5% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $31,500,000 | +54.0% | 525,000 | +10.5% | 0.19% | +34.0% |
| NVAX | New | NOVAVAX INC | $30,665,000 | – | 275,000 | +100.0% | 0.18% | – |
| IQIYI INCnote 3.750%12/0 | $29,894,000 | -7.4% | 29,689,000 | 0.0% | 0.18% | -19.3% | ||
| PANA | New | PANACEA ACQUISITION CORPcl a | $29,250,000 | – | 2,500,000 | +100.0% | 0.18% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $28,863,000 | – | 1,250,000 | +100.0% | 0.17% | – |
| CLVR | New | CLEVER LEAVES HOLDINGS INC | $28,730,000 | – | 2,478,079 | +100.0% | 0.17% | – |
| Sell | DERMTECH INC | $27,934,000 | +91.6% | 861,090 | -29.4% | 0.17% | +66.3% | |
| BIIB | New | BIOGEN INC | $25,221,000 | – | 103,000 | +100.0% | 0.15% | – |
| CNST | New | CONSTELLATION PHARMCETICLS I | $21,600,000 | – | 750,000 | +100.0% | 0.13% | – |
| BEKE | Buy | KE HLDGS INCsponsored ads | $21,108,000 | +2.8% | 343,000 | +2.4% | 0.13% | -10.6% |
| GRFS | Sell | GRIFOLS S Asp adr rep b nvt | $20,561,000 | -62.1% | 1,115,000 | -64.4% | 0.12% | -66.9% |
| New | IQIYI INCnote 4.000%12/1 | $20,000,000 | – | 20,000,000 | +100.0% | 0.12% | – | |
| ZEAL | Buy | ZEALAND PHARMA A/Ssponsored adr | $18,329,000 | -4.5% | 510,000 | +1.0% | 0.11% | -17.3% |
| ATENTO S A | $18,227,000 | +51.9% | 2,230,357 | 0.0% | 0.11% | +32.5% | ||
| PLRX | PLIANT THERAPEUTICS INC | $17,364,000 | +0.4% | 764,262 | 0.0% | 0.10% | -13.3% | |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $17,121,000 | +1.1% | 300,000 | -9.1% | 0.10% | -12.0% |
| RC | READY CAPITAL CORP | $16,810,000 | +11.2% | 1,350,226 | 0.0% | 0.10% | -3.8% | |
| INBX | Buy | INHIBRX INC | $16,815,000 | +136.5% | 510,000 | +29.1% | 0.10% | +106.1% |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $16,260,000 | +5.2% | 1,500,000 | 0.0% | 0.10% | -8.4% | |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $15,508,000 | -93.1% | 250,000 | -93.3% | 0.09% | -94.1% |
| BMYRT | Sell | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $14,768,000 | -85.1% | 21,400,000 | -51.4% | 0.09% | -87.0% |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $13,755,000 | – | 250,000 | +100.0% | 0.08% | – |
| New | NUANCE COMMUNICATIONS INCdbcv 1.000%12/1 | $13,052,000 | – | 7,000,000 | +100.0% | 0.08% | – | |
| XPO | New | XPO LOGISTICS INC | $13,112,000 | – | 110,000 | +100.0% | 0.08% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $12,240,000 | – | 225,000 | +100.0% | 0.07% | – |
| TINVU | New | TIGA ACQUISITION CORPunit 99/99/9999 | $11,426,000 | – | 1,080,000 | +100.0% | 0.07% | – |
| AVRO | Sell | AVROBIO INC | $11,082,000 | -18.9% | 795,000 | -24.3% | 0.07% | -29.5% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $10,968,000 | – | 200,000 | +100.0% | 0.07% | – |
| QURE | Sell | UNIQURE NV | $10,839,000 | -34.6% | 300,000 | -33.3% | 0.06% | -43.5% |
| CASU | New | CASCADE ACQUISITION CORPunit 99/99/9999 | $10,346,000 | – | 990,000 | +100.0% | 0.06% | – |
| KNTE | New | KINNATE BIOPHARMA INC | $9,945,000 | – | 250,000 | +100.0% | 0.06% | – |
| ALBO | Buy | ALBIREO PHARMA INC | $9,378,000 | +40.5% | 250,000 | +25.0% | 0.06% | +21.7% |
| SURF | New | SURFACE ONCOLOGY INC | $9,240,000 | – | 1,000,000 | +100.0% | 0.06% | – |
| New | GOSSAMER BIO INCnote 5.000% 6/0 | $9,032,000 | – | 10,000,000 | +100.0% | 0.05% | – | |
| ACIA | Buy | ACACIA COMMUNICATIONS INC | $7,296,000 | +80.4% | 100,000 | +66.7% | 0.04% | +57.1% |
| COGT | New | COGENT BIOSCIENCES INC | $6,738,000 | – | 600,000 | +100.0% | 0.04% | – |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $6,804,000 | – | 400,000 | +100.0% | 0.04% | – |
| IMGN | New | IMMUNOGEN INC | $6,450,000 | – | 1,000,000 | +100.0% | 0.04% | – |
| APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $5,930,000 | +54.8% | 3,522,000 | 0.0% | 0.04% | +38.5% | ||
| RADIUS HEALTH INCnote 3.000% 9/0 | $5,995,000 | +9.5% | 6,783,000 | 0.0% | 0.04% | -5.3% | ||
| CRIS | New | CURIS INC | $5,938,000 | – | 725,000 | +100.0% | 0.04% | – |
| MRVL | New | MARVELL TECHNOLOGY GROUP LTDcall | $5,943,000 | – | 125,000 | +100.0% | 0.04% | – |
| STTK | New | SHATTUCK LABS INC | $5,241,000 | – | 100,000 | +100.0% | 0.03% | – |
| SVRA | SAVARA INC | $5,120,000 | +5.5% | 4,452,086 | 0.0% | 0.03% | -8.8% | |
| TGTX | New | TG THERAPEUTICS INC | $5,202,000 | – | 100,000 | +100.0% | 0.03% | – |
| ISEE | IVERIC BIO INC | $5,215,000 | +22.5% | 754,740 | 0.0% | 0.03% | +6.9% | |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS IN | $5,187,000 | -71.6% | 67,600 | -84.0% | 0.03% | -75.4% |
| HMCOU | New | HUMANCO ACQUISITION CORPunit 12/08/2023 | $4,408,000 | – | 400,000 | +100.0% | 0.03% | – |
| MASS | New | 908 DEVICES INC | $4,271,000 | – | 75,000 | +100.0% | 0.03% | – |
| FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $4,145,000 | – | 100,000 | +100.0% | 0.02% | – |
| KURA | New | KURA ONCOLOGY INC | $4,083,000 | – | 125,000 | +100.0% | 0.02% | – |
| EQ | EQUILLIUM INC | $3,745,000 | -7.3% | 700,000 | 0.0% | 0.02% | -17.9% | |
| New | ISIS PHARMACEUTICALS INC DELnote 1.000%11/1 | $2,733,000 | – | 2,500,000 | +100.0% | 0.02% | – | |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $2,520,000 | -61.3% | 200,000 | -73.0% | 0.02% | -66.7% |
| IVA | Sell | INVENTIVA SAads | $2,320,000 | -62.8% | 160,000 | -69.7% | 0.01% | -67.4% |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $2,207,000 | – | 47,620 | +100.0% | 0.01% | – |
| BRMKWS | BROADMARK RLTY CAP INC*w exp 11/15/202 | $1,937,000 | -6.1% | 7,174,613 | 0.0% | 0.01% | -14.3% | |
| GOL | GOL LINHAS AEREAS INTELIGENTspon adr pfd new | $843,000 | +60.9% | 85,838 | 0.0% | 0.01% | +25.0% | |
| CEREW | New | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $758,000 | – | 134,175 | +100.0% | 0.01% | – |
| PAND | Exit | PANDION THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -45,000 | -100.0% | -0.01% | – |
| FUSN | Exit | FUSION PHARMACEUTICALS INC | $0 | – | -187,600 | -100.0% | -0.02% | – |
| CRDF | Exit | CARDIFF ONCOLOGY INC | $0 | – | -200,000 | -100.0% | -0.02% | – |
| QTNT | Exit | QUOTIENT LTD | $0 | – | -625,000 | -100.0% | -0.02% | – |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.03% | – |
| ARYBU | Exit | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $0 | – | -402,523 | -100.0% | -0.03% | – |
| TARA | Exit | PROTARA THERAPEUTICS INC | $0 | – | -425,000 | -100.0% | -0.05% | – |
| LQDA | Exit | LIQUIDIA TECHNOLOGIES INC | $0 | – | -1,865,350 | -100.0% | -0.06% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -550,000 | -100.0% | -0.06% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -150,000 | -100.0% | -0.08% | – |
| NAV | Exit | NAVISTAR INTL CORP NEW | $0 | – | -276,600 | -100.0% | -0.08% | – |
| CMPS | Exit | COMPASS PATHWAYS PLCsponsored ads | $0 | – | -362,940 | -100.0% | -0.09% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -1,000,000 | -100.0% | -0.10% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $0 | – | -2,515,762 | -100.0% | -0.14% | – |
| BRMK | Exit | BROADMARK RLTY CAP INCcall | $0 | – | -2,391,536 | -100.0% | -0.16% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -593,472 | -100.0% | -0.18% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -991,174 | -100.0% | -0.22% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -600,000 | -100.0% | -0.23% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -725,000 | -100.0% | -0.56% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -502,231 | -100.0% | -0.59% | – |
| LVGO | Exit | LIVONGO HEALTH INC | $0 | – | -830,000 | -100.0% | -0.80% | – |
| EQIX | Exit | EQUINIX INC | $0 | – | -200,164 | -100.0% | -1.05% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -5,097,546 | -100.0% | -1.08% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -1,225,000 | -100.0% | -1.16% | – |
| GD | Exit | GENERAL DYNAMICS CORP | $0 | – | -1,277,107 | -100.0% | -1.22% | – |
| PANW | Exit | PALO ALTO NETWORKS INC | $0 | – | -887,892 | -100.0% | -1.50% | – |
| INFO | Exit | IHS MARKIT LTD | $0 | – | -3,812,944 | -100.0% | -2.07% | – |
| EMB | Exit | ISHARES TRput | $0 | – | -288,900 | -100.0% | -2.22% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -5,860,000 | -100.0% | -3.45% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.